课题基金 / 基金详情

Loss of Keratin 76 in Thymic Epithelial Cells affects Skin Tissue Self-Antigens presentation in the Thymus and disrupts T cell tolerance

Loss of Keratin 76 in Thymic Epithelial Cells affects Skin Tissue Self-Antigens presentation in the Thymus and disrupts T cell tolerance
胸腺上皮细胞中角蛋白 76 的丢失会影响胸腺中皮肤组织自身抗原的呈现并破坏 T 细胞耐受性
批准号:
2442036
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
角蛋白是在上皮细胞中表达的细胞骨架蛋白,包括髓质胸腺上皮细胞(mTECs)。最近的研究已经揭示了角蛋白在调节免疫中的作用(Hobbs等人,2015)。角蛋白76(Krt 76)在口腔、鳞状胃和胸腺的上皮细胞中表达,并且显示在口腔癌和胃癌中起免疫调节作用(塞凯拉等人,2018年)。然而,Krt 76-/-成年小鼠显示慢性炎症表型,目前还不清楚表达Krt 76的胸腺上皮细胞(TEC)如何与免疫系统相互作用并调节免疫系统。我的目的是研究Krt 76在胸腺中的特异性缺失如何影响T细胞发育,并证明其在与细胞成分沟通以调节皮肤特异性组织自身抗原(TSA)表达中的作用。在胸腺内。我们鉴定了Krt 76在其他终末分化的mTEC标志物中的共表达,并且在人类和小鼠哈萨尔小体中,具有不清楚功能的独特胸腺结构。我们将胎儿Krt 76-/-胸腺移植到无胸腺裸鼠的肾包膜中,这证实了成人Krt 76-/-炎性表型是由特异性地在胸腺中的Krt 76破坏驱动的。基于Michelson等人(Cell 2022)的最新研究,我们假设Krt 76 + TEC可能负责TSA的表达。对他们发表的数据集的分析表明,Krt 76 + mTEC表达特异性皮肤TSA。此外,我们进行了Krt 76-/-胸腺的scRNA-seq以研究Krt 76-/-胸腺中的细胞和分子差异,并评估了调节这些变化的分子机制。此外,流式细胞术和免疫组织化学分析显示,年轻成年Krt 76-/-小鼠外周中的效应T细胞数量较高,但在较早的时间点并非如此。我们的研究结果证实,角蛋白在胸腺可以影响T细胞的成熟,特别是通过启动T细胞特异性针对皮肤TSA。这项研究强调了角蛋白在严格调控的免疫过程中的基本作用。这项研究将Krt 76 + TEC与皮肤免疫稳态直接联系起来,这可能成为未来治疗干预的主要新靶点。"
英文摘要
"Keratins are cytoskeletal proteins expressed in epithelial cells, including medullary thymic epithelial cells (mTECs). Recent studies have uncovered a role for keratins in regulating immunity (Hobbs et al., 2015). Keratin76 (Krt76) is expressed in epithelial cells of the oral cavity, squamous stomach and thymus, and was shown to play an immunomodulatory role in oral and gastric cancer (Sequeira et al., 2018). Krt76-/- adult mice display a chronic inflammation phenotype, however, it remains unclear how thymic epithelial cells (TECs) expressing Krt76 are interacting with and regulating the immune system.I aim to investigate how loss of Krt76 specifically in the thymus impacts T cell development and demonstrate its role in communicating with cellular components to regulate the expression of skin-specific tissue self-antigens (TSAs) within the thymus. We identified co-expression of Krt76 amongst other terminally differentiated mTEC markers and in human and mice Hassall's Corpuscles, unique thymic structures with an unclear function. We transplanted foetal Krt76-/- thymi into the renal capsule of athymic nude mice which confirmed that adult Krt76-/- inflammatory phenotype was driven by Krt76 disruption specifically in the thymus. We hypothesised that Krt76+ TECs may be responsible for the expression of TSAs, based on the recent study by Michelson et al. (Cell 2022). Analysis of their published dataset indicated expression of specific skin TSAs by Krt76+ mTECs. Additionally, we carried out scRNA-seq of Krt76-/- thymi to investigate the cellular and molecular differences in the Krt76-/- thymi, and assessed the molecular mechanisms regulating these changes. Additionally, flow cytometry and immunohistochemistry analysis revealed higher numbers of effector T cells in the periphery of young adult Krt76-/- mice, but not at earlier timepoints. Our results confirm that keratins in the thymus can impact the maturation of T cells, in particular by priming T cells specifically against skin TSAs. This study highlights the fundamental role of keratins in tightly regulated immunological processes. This study places Krt76+ TECs in direct communication with skin immune homeostasis, which could present as a major new target for future therapeutic interventions."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Keratin 80通过上调FBXL4降解Drp1抑制线粒体分裂阻断非小细胞肺癌凋亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    童岳阳
  • 依托单位:
M-keratin介导下MSCs迁移体募集细胞和调控分化的协同机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    陈吾雅
  • 依托单位:
Keratin8/18调控钙铁离子稳态在急性高眼压视网膜神经节细胞损伤中的作用及机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    53万元
  • 批准年份:
    2021
  • 负责人:
    王凯军
  • 依托单位:
Keratin 8重塑代谢稳态调控慢加急性肝衰竭肝细胞代偿性再生的作用及机制研究
  • 批准号:
    82100648
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    叶俊钊
  • 依托单位: